Key facts
- It has raised $780K; the latest was Later Stage VC ($780K) in Jan 2026.
- Notable investors include BR Angels, JBR Partners Capital, Orgânica Participações.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Novvo Bem Estar
- ·The full record, as it builds
Funding rounds
No funding rounds for Novvo Bem Estar are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Novvo Bem Estar
Producer of a pre-drink pill intended to neutralize alcohol toxins and prevent hangover symptoms. The company offers scientifically-backed, expert-developed products tested in international laboratories, enabling consumers who enjoy socializing and drinking to feel refreshed and avoid hangovers the next day.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Sao Paulo, Brazil
- Founded
- 2015
- Employees
- 21
- Website
- novvo.com.br/
- Ownership
- Privately Held (backing)
Novvo Bem Estar doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Novvo Bem Estar shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Novvo Bem Estar in its N-PORT filings yet. We sweep new filings monthly.